AWY0

Research AWY0 on Bullrun: market cap EUR 761.21K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAWY0
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 761.21K
• Financial periodFY2025
• Net income-EUR 14.92M
• Free cash flow-EUR 15.65M

Valuation Snapshot

latest market cap is EUR 761.21K.

About AWY0

Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company's lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications.

Frequently asked questions

What is AWY0's market cap?

AWY0's market capitalization is EUR 761.21K.

What does AWY0 do?

Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.